Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Change in Cash: 2018-2024

Historic Change in Cash for Gossamer Bio (GOSS) over the last 7 years, with Dec 2024 value amounting to $14.0 million.

  • Gossamer Bio's Change in Cash rose 70.25% to -$17.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$19.5 million, marking a year-over-year increase of 63.93%. This contributed to the annual value of $14.0 million for FY2024, which is 117.49% up from last year.
  • As of FY2024, Gossamer Bio's Change in Cash stood at $14.0 million, which was up 117.49% from -$79.9 million recorded in FY2023.
  • In the past 5 years, Gossamer Bio's Change in Cash registered a high of $351.5 million during FY2020, and its lowest value of -$303.2 million during FY2021.
  • Its 3-year average for Change in Cash is -$45.8 million, with a median of -$71.5 million in 2022.
  • In the last 5 years, Gossamer Bio's Change in Cash soared by 1,084.80% in 2020 and then plummeted by 186.24% in 2021.
  • Gossamer Bio's Change in Cash (Yearly) stood at $351.5 million in 2020, then plummeted by 186.24% to -$303.2 million in 2021, then skyrocketed by 76.42% to -$71.5 million in 2022, then declined by 11.71% to -$79.9 million in 2023, then surged by 117.49% to $14.0 million in 2024.